Case number 1:18-cv-01787
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Prinston Pharmaceutical Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 20, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the entry of the Consent Judgment in Lead Case No. 18-1689-CFC. (nmf) |
| Mar 26, 2019 | 22 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Rule 26(a)(1) filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| Mar 5, 2019 | 21 | Scheduling Order (21) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all papers shall be filed in Lead Case No. 18-1689-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery matters and protective orders. Joinder of Parties due by 4/30/2020. Amended Pleadings due by 4/30/2020. Fact Discovery completed by 3/22/2020. Joint Claim Construction Brief due by 2/28/2020. A Markman Hearing is set for 4/7/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 4/8/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/19/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Mar 5, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE 18-1689-CFC ONLY. (nmf) |
| Mar 5, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01689-CFC-SRF et al.(cak) |
| Mar 4, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 3/4/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 20 | Letter to The Honorable Colm F. Connolly (2) |
| Feb 28, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference on 3/4/2019 at 02:30 PM before Judge Colm F. Connolly is rescheduled as a Telephonic Scheduling Conference per the letter and proposed scheduling order filed today stating that there are no areas of dispute. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 20 | Proposed Order (21) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Egan, Brian) |
| Jan 25, 2019 | 19 | Answer to Counterclaim (16) Docket Text: ANSWER to [16] Answer to Complaint,, Counterclaim, -- Answer to Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jan 24, 2019 | 18 | Notice of Change of Address (3) Docket Text: NOTICE of Change of Address by Stamatios Stamoulis (Stamoulis, Stamatios) |
| Jan 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Richard Juang,Ronald M. Daignault for Prinston Pharmaceutical Inc., Solco Healthcare US, LLC, Zhejiang Huahai Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jan 4, 2019 | 15 | SO ORDERED (3) Docket Text: SO ORDERED, re [14] Stipulation and Order Dismissing Complaint as to Defendants Zhejiang Huahai Pharmaceutical Co., Ltd., and Solco Healthcare US, LLC and Amendment of Caption filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Party Solco Healthcare US, LLC and Zhejiang Huahai Pharmaceutical Co., Ltd. terminated. Signed by Judge Colm F. Connolly on 1/4/2019. Signed by Judge Colm F. Connolly on 1/4/2019. (fms) |
| Jan 4, 2019 | 16 | Answer to Complaint (22) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and, COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios) |
| Jan 4, 2019 | 17 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd. for Prinston Pharmaceutical Inc. filed by Prinston Pharmaceutical Inc.. (Stamoulis, Stamatios) |
| Jan 3, 2019 | 13 | Order Setting Scheduling Conference (9) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Jan 3, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang filed by Zhejiang Huahai Pharmaceutical Co., Ltd., Solco Healthcare US, LLC, Prinston Pharmaceutical Inc. Signed by Judge Colm F. Connolly on 1/3/2019. (fms) |
| Jan 3, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of D.I. [12] has been replaced with a corrected version per request of counsel. (nmf) |
| Jan 3, 2019 | 14 | Stipulation (3) Docket Text: Joint STIPULATION Dismissing Complaint as to Defendants Zhejiang Huahai Pharmaceutical Co., Ltd., and Solco Healthcare US, LLC and Amendment of Caption by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Jan 2, 2019 | 12 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by Prinston Pharmaceutical Inc., Solco Healthcare US, LLC, Zhejiang Huahai Pharmaceutical Co., Ltd.. (Stamoulis, Stamatios) (Main Document 12 replaced on 1/3/2019) (nmf, ). |
| Dec 28, 2018 | 11 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
| Dec 17, 2018 | 10 | Order (8) Docket Text: ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 7, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME to Respond to Complaint to January 11, 2019 filed by Zhejiang Huahai Pharmaceutical Co., Ltd., Solco Healthcare US, LLC, Prinston Pharmaceutical Inc., Set/Reset Answer Deadlines: Prinston Pharmaceutical Inc. answer due 1/11/2019; Solco Healthcare US, LLC answer due 1/11/2019; Zhejiang Huahai Pharmaceutical Co., Ltd. answer due 1/11/2019. Signed by Judge Colm F. Connolly on 12/7/2018. (fms) |
| Dec 7, 2018 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to January 11, 2019 - filed by Prinston Pharmaceutical Inc., Solco Healthcare US, LLC, Zhejiang Huahai Pharmaceutical Co., Ltd.. (Stamoulis, Stamatios) |
| Nov 27, 2018 | 6 | Declaration (9) Docket Text: DECLARATION of Mailing on Prinston Pharmaceuticals, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 27, 2018 | 7 | Declaration (9) Docket Text: DECLARATION of Mailing on Solco Healthcare US, LLC by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 27, 2018 | 8 | Declaration (9) Docket Text: DECLARATION of Mailing on Zhejiang Huahai Pharmaceuticals Co., Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 14, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01757-CFC, 1:18-cv-01758-CFC, 1:18-cv-01762-CFC through 1:18-cv-01765-CFC, 1:18-cv-01779-CFC, 1:18-cv-01783-CFC, and 1:18-cv-01785-CFC through 1:18-cv-01789-CFC (rjb) |
| Nov 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Prinston Pharmaceutical Inc. on 11/13/2018; Solco Healthcare US, LLC on 11/13/2018; Zhejiang Huahai Pharmaceutical Co., Ltd. on 11/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Nov 13, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (lak) |
| Nov 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957 B2 ;9,949,998 B2. (lak) |
| Nov 13, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/5/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 2/1/2022. (lak) |
| Nov 13, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Nov 13, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 13, 2018 | 1 | Exhibit 1-2 (87) |
| Nov 13, 2018 | 1 | Complaint* (1) |
